Alan Gray is getting a new look. We should be back online shortly.
Our latest thinking on the issues that matter most in business and management.
Track October mass-tort developments, from social media and GLP-1 claims to new device litigation, and what they mean for insurers.
Claims costs are rising faster than CPI. See where repair, medical and legal inflation can leave reserves and claims oversight behind.
January renewals are approaching. Reconcile claims data and recoverables now to reduce questions and strengthen your reinsurance submission.
A billing flag isn’t a saving. The real test of legal invoice software is what survives appeal, minus what it costs to get there.
When an AI agent drains a business account, who pays? The liability chain runs from developer to deploying business — and insurers are narrowing silent cover.
Defense costs are climbing for 76% of claims teams, nuclear verdicts jumped 40.7%, and AI is shifting from adoption to accountability.
Regulators call NAION a very rare semaglutide side effect. The studies disagree, and that gap is exactly what makes these claims hard to evaluate.
Insurers are owed $418B by reinsurers, up 30% since 2020. When collections slip, the statutory penalty hits surplus — not just cash flow.
Federal mass-tort inventories kept climbing in September, led by a 265% year-to-date jump in Depo-Provera and a new MDL for PFAS firefighter gear.
Privacy Policy | © 2026 Alan Gray. All Rights Reserved.